metformin has been researched along with Intestinal Obstruction in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Intestinal Obstruction: Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lalau, JD | 1 |
| Race, JM | 1 |
| Andreelli, F | 1 |
| Lacroix, C | 1 |
| Canarelli, JP | 1 |
1 other study available for metformin and Intestinal Obstruction
| Article | Year |
|---|---|
Metformin retention independent of renal failure in intestinal occlusion.
Topics: Acute Kidney Injury; Aged; Animals; Blood Glucose; Cecum; Creatinine; Diabetes Mellitus, Type 2; Fem | 2001 |